Cibc Private Wealth Group, LLC Immix Biopharma, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $56.1 Billion
- Q3 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 10,000 shares of IMMX stock, worth $42,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$42,100% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMMX
# of Institutions
34Shares Held
3.15MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY850KShares$3.58 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA730KShares$3.07 Million0.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$1.71 Million11.13% of portfolio
-
Geode Capital Management, LLC Boston, MA187KShares$789,2730.0% of portfolio
-
Morgan Stanley New York, NY121KShares$508,0200.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $58.6M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...